Isunakinra as Monotherapy and Combined with Nivolumab for Treatment Resistant Advanced Solid Tumours: Exploratory Effect Data, Tolerability, and Pharmacokinetics from a Dose Escalation Trial

Opdivo (nivolumab) - Ono Pharma, BMS

Kineret (anakinra) - SOBI

isunakinra (EBI-005) - Buzzard Pharma

Carlos Becerra 1; H. Olivecrona 2; M. De Château 3; S.A. Paulson 1

Oct 23, 2023